333 filings
Page 6 of 17
8-K
j4y2xsm b6
16 Mar 22
INmune Bio, Inc. to Participate in the 32nd Annual Oppenheimer Healthcare Conference and the 2022 Maxim Group Virtual Growth Conference
4:00pm
8-K
eh7dxqfrfiqes4
4 Mar 22
INmune Bio, Inc. Announces Fourth Quarter and Full Year 2021 Results and Provides Business Update
4:00pm
8-K
8t1mupr
23 Feb 22
INmune Bio, Inc. to Report Fourth Quarter 2021 Financial Results and Provide a Corporate Update on Thursday, March 3
4:31pm
8-K
z9vvn usyx
9 Feb 22
INmune Bio, Inc. to Present at the BIO CEO & Investor Conference
9:32am
8-K
mjuiwjkkfia ul
27 Jan 22
Other Events
4:00pm
8-A12B/A
f2yvjlume 88slojx
21 Dec 21
Registration of securities on exchange (amended)
4:04pm
8-K
tk4nq1zzwpx24 m4
21 Dec 21
Other Events
4:00pm
8-K
p29ugc rjd1g
1 Dec 21
Other Events
4:54pm
8-K
hd5bz6iz fubqenaxf
5 Nov 21
Other Events
4:00pm
8-K
g6ni5rrk5sz87b
4 Nov 21
INmune Bio, Inc. Announces Third Quarter 2021 Results and Provides Business Update
4:01pm
8-K
2d11kw hv
4 Nov 21
HARNESSING THE POWER OF THE INNATE IMMUNE SYSTEM Targeting Innate Immune Dysfunction INMB INVESTOR PRESENTATION November 2021
9:00am
8-K
x7zwnlox j8zg1dmq
28 Oct 21
INmune Bio, Inc. Announces Multiple Oral and Poster Presentations at the 14th Clinical Trials on Alzheimer’s Disease (CTAD) Annual Meeting
4:30pm
8-K
xwb6dot7x
26 Oct 21
INmune Bio, Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on Wednesday, November 3
4:35pm
8-K
m0ftlinegsow5
28 Sep 21
INmune Bio, Inc. to Participate in the B. Riley Fall 2021 Best Ideas in Oncology Series
4:00pm
8-K
hmvh3h01wt hnn
22 Sep 21
INmune Bio, Inc. Announces Participation at Upcoming Investor Conferences
4:00pm
424B3
vrwgq200nsfsgr8hr5
21 Sep 21
Prospectus supplement
5:05pm
EFFECT
p1hf 9893x
20 Sep 21
Notice of effectiveness
12:15am
8-K
pnk8w6u
15 Sep 21
Entry into a Material Definitive Agreement
12:00am